Startup entity

Axios

Company

Axios is most often covered alongside Anthropic, which appears in 2 of these 3 stories. regulation accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Across a 70-day span, the pace is roughly 0.3 stories per week.

Last mentioned: 18h ago

RSS updates
Share

Entity pulse

Recent coverage · Axios

→
3 stories
6 avg impact
33% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 33 percentage points.

  • 33% positive
  • 67% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Axios

Axios is most often covered alongside Anthropic, which appears in 2 of these 3 stories. regulation accounts for 2 of the 3 tracked stories, while 1 other category carries the remainder. Across a 70-day span, the pace is roughly 0.3 stories per week. At 6, the average consequence score sits below the same-window beat average of 6.1. Each story carries 2.3 original sources on average, compared with 2.4 for the broader beat in this window. Axios appears in 3 tracked Startup stories published from July 21, 2026 through September 28, 2026.

Stories tracked
3
Per week
0.3
Sources per story
2.3

Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 311 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Axios. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Private White House dinner

    Trump and Anthropic CEO Dario Amodei meet one-on-one for the first time at the White House, following CNBC confirmation.

  2. State dinner for Xi Jinping

    Trump hosts Chinese President Xi Jinping; tech leaders Altman, Musk, Huang and Zuckerberg attend, while Amodei is absent due to a scheduling conflict.

Stories mentioning Axios 3

Funding Rounds Strongly positive

Colossal seeks $20B–$30B funding round

Colossal Biosciences is seeking a valuation of $20–$30 billion, nearly 3x its previous valuation, as it generates revenue, spins out startups, and has government clients and AI-driven assets.

2 sources

Axios is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.